-
Product Insights
Macular Edema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Macular Edema is swelling or fluid retention in a specialized part of the retina called the macula. Symptoms of macular edema include blurred or wavy central vision and/or colors appear changed. There are many causes of macular edema. It is frequently associated with diabetes, where damaged blood vessels in the retina begin to leak fluids, including small amounts of blood, into the retina. Other causes include retinal vein occlusion, side effects of certain medications and certain genetic disorders, such as...
-
Product Insights
Retinal Vein Occlusion Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Retinal Vein Occlusion is a blockage in one of the veins returning blood flow from the retina. Its predisposing factors are atherosclerosis, macular edema, diabetes, high blood pressure, high cholesterol, and age. The Retinal Vein Occlusion pipeline market research report provides comprehensive information on the therapeutics under development for Retinal Vein Occlusion, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action...
-
Product Insights
Dry (Atrophic) Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Dry (Atrophic) Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Dry (Atrophic) Macular Degeneration pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dry (Atrophic) Macular Degeneration, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history...
-
Product Insights
Allergic Rhino-Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Allergic Rhino-Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Allergic Rhino-Conjunctivitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Allergic Rhino-Conjunctivitis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Anterior Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Anterior Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Anterior Uveitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anterior Uveitis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Leber’s hereditary optic neuropathy (LHON) symptoms include eye pain or discomfort, numbness, tingling, and clouding of vision. Predisposing factors include age, tobacco smoke, alcohol, cancer-treating drugs, stress-related chemicals, some antibiotics, and cyanogens. The LHON pipeline drugs market research report provides an analysis of the LHON drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history,...
-
Product Insights
Retinopathy of Prematurity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinopathy Of Prematurity – Drugs In Development, 2022, provides an overview of the Retinopathy Of Prematurity (Ophthalmology) pipeline landscape. Retinopathy of prematurity (ROP) is a disease that affects immature vasculature in the eyes of premature babies. This disorder which usually develops in both eyes is one of the most common causes of visual loss in childhood and can lead to lifelong vision impairment and blindness Risk factors for the development...
-
Product Insights
Cataract Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Cataract is a clouding of the normally clear lens of eye that affects vision. Symptoms include clouded, blurred or dim vision, increasing difficulty with vision at night, fading or yellowing of colors, double vision in a single eye and frequent prescription changes in eye wear. The cataract pipeline drugs market research report provides an analysis of the cataract drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The guide also covers...
-
Product Insights
Allergic Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The symptoms of Allergic Conjunctivitis include intense itching, puffy eyelids, widened (dilated) vessels in the clear tissue covering the white of the eye, and stringy eye discharge. Its treatment includes antihistamine or anti-inflammatory medications. The Allergic Conjunctivitis pipeline market research report provides comprehensive information on the therapeutics under development for Allergic Conjunctivitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action...
-
Product Insights
Corneal Neovascularization Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The predisposing factors of Corneal Neovascularization include infections, trauma to the eye, chemical burns, immune system diseases, and certain other eye conditions, such as uveitis and glaucoma. Its symptoms are irritation in the eyes, dryness and pink eye or conjunctivitis, and light sensitivity. The Corneal Neovascularization pipeline market research report provides comprehensive information on the therapeutics under development for Corneal Neovascularization, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.